During 2025, near-infrared (NIR) spectroscopy has accelerated its transition from a mature analytical technique into a digitally enabled cornerstone of biopharmaceutical manufacturing and quality control. Advances in miniaturized instrumentation, process analytical technology (PAT), chemometrics, artificial intelligence (AI), and real-time process control technologies have driven NIR spectroscopy into new roles spanning upstream fermentation, downstream processing, raw material characterization, and continuous manufacturing. This article reviews and contextualizes ten influential peer-reviewed publications from 2025 that collectively define the current state and near-term trajectory of NIR spectroscopy in biopharmaceutical analysis.